SCHEMBL1720327

SCHEMBL1720327

CCCN1c2[nH]c(=O)[nH]c(=O)c2NC1c1ccc(NCc2cccc(C(F)(F)F)c2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.38
VNN1 O95497 1/20 0.37
NR3C1 P04150 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
SCD O00767 2/20 0.36
GAA P10253 1/20 0.35
ROCK2 O75116 2/20 0.35
PRKACA P17612 2/20 0.35
GSK3B P49841 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
MKNK2 Q9HBH9 2/20 0.35
CDC7 O00311 1/20 0.35
MAP4K4 O95819 1/20 0.35
PIM1 P11309 1/20 0.35
CDK2 P24941 1/20 0.35
HIPK2 Q9H2X6 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1697136 0.76 ADORA2B (0.47) CDK2ADORA3ADORA2AADORA2BRPS6KA3
SCHEMBL1721018 0.75 EGFR (0.38) EGFRVNN1HDAC3HDAC1HDAC2
SCHEMBL1720325 0.72 ADORA3 (0.42) EGFRSCDCDK2ADORA3ADORA2A
SCHEMBL10224410 0.67 KDM1A (0.58) EGFRVNN1HDAC3HDAC1HDAC2
SCHEMBL1290422 0.67 KDM1A (0.58) EGFRVNN1HDAC3HDAC1HDAC2
SCHEMBL1290421 0.67 KDM1A (0.58) EGFRVNN1HDAC3HDAC1HDAC2
SCHEMBL20731028 0.67 PTGS1 (0.55) EGFRVNN1HDAC3HDAC1HDAC2
SCHEMBL2687202 0.67 ADORA2B (0.51) CDK2ADORA3ADORA2AADORA2BRPS6KA3
Hydrochloric Acid SCHEMBL15346052 0.66 KDM1A (0.57) EGFRVNN1HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL15346054 0.66 KDM1A (0.57) EGFRVNN1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed